Adenoma benign Active Not Recruiting Phase 4 Trials for Octreotide (DB00104)

Also known as: Adenomas / Adenoma / Adenoma benign NOS / Adenoma NOS

IndicationStatusPhase
DBCOND0017261 (Adenoma benign)Active Not Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02032784Prophylactic Octreotide to Prevent Post Duodenal EMR and Ampullectomy BleedingPrevention